FDA Warns Medtronic Unit Over Handling Of User Complaints
Medtronic Inc.'s neuromodulation unit was hit with a warning letter from the U.S. Food and Drug Administration that was made public Tuesday over issues stemming from the company's complaint handling processes...To view the full article, register now.
Already a subscriber? Click here to view full article